NuVasive has introduced the enlargement of its Superior Supplies Science (AMS) implant portfolio with the business launch of the Modulus XLIF twin sided plate, and the receipt of 510(ok) clearances from the US Meals and Drug Administration (FDA) for Modulus ALIF and Cohere TLIF-O.
“With these new choices, NuVasive strengthens its AMS portfolio to equip surgeons with best-in-class know-how for a wide range of thoracolumbar procedures,” stated Matt Hyperlink, president of NuVasive. “NuVasive’s continued R&D initiatives underscore the Firm’s dedication to broaden inside key procedural backbone segments and ship differentiated know-how to help higher affected person outcomes.”
The NuVasive AMS implant portfolio consists of proprietary floor and structural applied sciences to boost the osseointegration and biomechanical properties of surgical supplies utilized in backbone procedures. Adhering to the core rules of floor, construction and imaging, NuVasive’s Modulus and Cohere implants are designed for fusion, combining the inherent advantages of porosity with the advantageous materials properties of titanium and PEEK, respectively.
The NuVasive Modulus XLIF Twin Sided Plate is a low-profile, anti-migration plate that enables for 2 factors of fixation in eXtreme Lateral Interbody Fusion (XLIF) surgical procedures. This implant builds upon NuVasive’s Modulus XLIF plate portfolio, offering individualised options on the discretion of the surgeon, notably in multi-stage procedures or within the occasion of anterior longitudinal ligament launch. Moreover, simplified instrumentation permits surgeons to position the plate earlier than or after insertion of the Modulus XLIF implant.
“Since utilizing the Modulus XLIF implant, I’ve seen extraordinarily beneficial medical outcomes with my sufferers,” stated Mark Wang, orthopaedic backbone surgeon at Backbone Institute of Arizona. “Now, with the twin sided plate, I can use Modulus XLIF and add a plate when the affected person and pathologic options name for it. NuVasive’s complete portfolio equips me with the suitable instruments to fulfill the wants of my sufferers.”
Additional rounding out the Modulus implant portfolio, NuVasive lately acquired 510(ok) clearance of Modulus ALIF, a porous titanium implant engineered for the anterior lumbar interbody fusion (ALIF) process. Modulus ALIF is a low-profile implant designed to be used in each supine and lateral ALIF (XALIF)—a key element of the X360 system—and is the corporate’s first AMS providing for the ALIF market. Moreover, the corporate acquired 510(ok) clearance of Cohere TLIF-O, a porous PEEK implant engineered for the transforaminal lumbar interbody fusion (TLIF) process.